Study In Rheumatoid Arthritis

An Open Label In-Vitro, In-Vivo Study To Evaluate The Anti-Inflammatory Action Of Gugguluthikthakam Kashaya And Simhanada Guggulu Followed By Clinical Study In Rheumatoid Arthritis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/10/037469

Enrollment

Registered

2021-10-22

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Eligible subjects either male or female with diagnosed RA according to the revised 2010 American College of Rheumatology (ACR) criteria and Disease Activity Score (DAS).

Exclusion criteria

Exclusion criteria: Deformities and malformations of Musculoskeletal system, Pregnancy and lactation and RA Secondary to any disease will be excluded.

Design outcomes

Primary

Measure	Time frame
The outcome expected is a change in the criterias - ESR, CRP, RF FactorTimepoint: 60 days	—

Secondary

Measure	Time frame
Change in Das 28 (Disease Activity Score 28), Vas Score.Timepoint: 60 days	—

Countries

India

Contacts

Public ContactSREELEKSHMI G U

Mandsaur Institute Of Ayurveda Education And Research, Mandsaur

dr.rpmishra@gmail.com7907709700

Outcome results